Krystal Biotech (KRYS) Shares Outstanding (2016 - 2026)
Krystal Biotech (KRYS) posted quarterly Shares Outstanding (Entity) of $29.6 million for Q2 2026, up 2.31% year-over-year from $28.9 million in Q2 2025, and up 0.54% on a QoQ basis from $29.4 million in Q1 2026.
Krystal Biotech (KRYS) Shares Outstanding (2016 - 2026) Analysis & Trends
Krystal Biotech has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $29.6 million in Q2 2026.
- Shares Outstanding (Entity) for Q2 2026 came in at $29.6 million, up 2.31% year-over-year; the trailing twelve-month figure through Jun 2026 was $29.6 million (up 2.31% YoY), and the FY2025 annual result was $29.2 million, up 1.38% from the prior year.
- Shares Outstanding (Entity) climbed to $29.6 million in Q2 2026, from $29.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $29.6 million in Q2 2026 and troughed at $25.2 million in Q1 2022.
- A 5-year average of $27.9 million and a median of $28.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest annual swing landed in 2022, when Shares Outstanding (Entity) gained 15.61%; it then gained 0.76% in 2025.
- A 5-year view of Shares Outstanding (Entity) shows it stood at $25.8 million in 2022, then rose by 9.6% to $28.2 million in 2023, then climbed by 1.97% to $28.8 million in 2024, then grew by 1.38% to $29.2 million in 2025, then rose by 1.38% to $29.6 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $29.6 million in Q2 2026, $29.4 million in Q1 2026, and $29.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 29.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.53 Mn |
| Mar 31, 2026 | 29.29 Mn |
| Dec 31, 2025 | 28.94 Mn |
| Sep 30, 2025 | 28.95 Mn |
| Jun 30, 2025 | 28.91 Mn |
| Mar 31, 2025 | 28.82 Mn |
| Dec 31, 2024 | 28.59 Mn |
| Sep 30, 2024 | 28.72 Mn |
| Jun 30, 2024 | 28.60 Mn |
| Mar 31, 2024 | 28.30 Mn |
| Dec 31, 2023 | 27.15 Mn |
| Sep 30, 2023 | 28.04 Mn |
| Jun 30, 2023 | 26.66 Mn |
| Mar 31, 2023 | 25.71 Mn |
| Dec 31, 2022 | 25.49 Mn |
| Sep 30, 2022 | 25.62 Mn |
| Jun 30, 2022 | 25.55 Mn |
| Mar 31, 2022 | 25.11 Mn |
| Dec 31, 2021 | 22.20 Mn |
| Sep 30, 2021 | 22.21 Mn |